Kibow® Biotech, founded in 1997, develops science-based solutions to support kidney health by targeting the gut–kidney axis. Its approach focuses on strengthening the gut microbiome, reducing harmful metabolites, and lowering inflammation—key factors in kidney disease progression. Kibow’s portfolio includes clinically studied probiotics like Renadyl®, along with Kibow Fortis® and kidney-specific products designed to support patients at different stages of care.